Pharmaceutical Commerce

Austin Russian: How Rare Disease Therapy Launches will Adapt

In part two of Pharmaceutical Commerce’s conversation with Austin Russian, SVP of Program Excellence at PANTHERx Rare, ...
Pharmaceutical Commerce

Angelini to Expand into US Rare Disease Market with Catalyst Acquisition

Angelini Pharma is acquiring Catalyst Pharmaceuticals in a $4.1 billion transaction that expands its presence in the US rare ...
Pharmaceutical Commerce

Asembia AXS26: What Does CGT Distribution and Access Look Like?

In the second part of her interview with Pharmaceutical Commerce live from Asembia AXS26, Jennifer Lospinoso, managing ...